TOANO, Va., Jan. 27, 2026 (GLOBE NEWSWIRE) -- C&F Financial Corporation (the Corporation) (NASDAQ: CFFI), the holding company for C&F Bank, today reported consolidated net income of $6.7 million for the fourth quarter of 2025, compared to $6.0 million for the fourth quarter of 2024. The Corporation reported consolidated net income of $27.0 million for the year ended December 31, 2025, compared to $19.9 million for the year ended December 31, 2024. The following table presents selected financial performance highlights for the periods indicated:

NEW YORK, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Cogent Communications Holdings, Inc. (“Cogent” or the “Company”) (NASDAQ: CCOI). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

NEW YORK, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Ultragenyx Pharmaceutical Inc. (“Ultragenyx” or the “Company”) (NASDAQ: RARE). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

"The whole industry, we were on a path that we were working to get to 40 to 50% EVs by 2030, so now that the regulatory environment has changed and the consumer incentives have gone, there is going to be slower EV adoption," says General Motors CEO Mary Barra. Watch our full interview here: https://bloom.bg/4qJgBIu

NEW YORK, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Nutanix, Inc. (“Nutanix” or the “Company”) (NASDAQ: NTNX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

NEW YORK, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Mereo BioPharma Group plc (“Mereo” or the “Company”) (NASDAQ: MREO). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

Capital One's card business drives growth, with revenue surging after the Discover deal even as rate-cap risks and a premium valuation affect near-term buying.

BABA's "All Others" unit's revenues decline 25% YoY in Q2 FY26, widening losses and dragging growth despite strength in core businesses.

SKIL and UDMY take diverging paths in online learning, with AI initiatives, uneven growth trends and stark valuation gaps shaping the buy debate.

AVO's 10% revenue rebound reflects stronger avocado volumes and rising blueberries and mangoes, raising questions about durable multi-segment growth.

NEW YORK, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Beyond Meat, Inc. (“Beyond Meat” or the “Company”) (NASDAQ: BYND) and certain officers. The class action, filed in the United States District Court for the Central District of California, and docketed under 26-cv-00742, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Beyond Meat securities between February 27, 2025 and November 11, 2025, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants' violations of the …

NEW YORK, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Corcept Therapeutics Incorporated (“Corcept” or the “Company”) (NASDAQ: CORT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

ATLANTA, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC reminds investors of the deadline to seek to be appointed lead plaintiff in the following class action lawsuits:

Roper Technologies, Inc. (ROP) Q4 2025 Earnings Call Transcript

Northrop Grumman Corporation (NOC) Q4 2025 Earnings Call Transcript

Northeast Bank (NBN) Q2 2026 Earnings Call Transcript

Late January brought snow, ice, and single-digit to sub-zero temperatures throughout much of the United States. In advance of that, several energy stocks rallied hard, particularly those tied to natural gas.

President Donald Trump threatened to hike tariffs on goods imported from South Korea to 25%, citing the failure of the country's legislature to codify the trade deal. The new rate would apply to autos, lumber, pharmaceutical products and "all other Reciprocal TARIFFS", under which the president set a 15% levy on South Korean exports.

NEW YORK, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Zenas BioPharma, Inc. (“Zenas” or the “Company”) (NASDAQ: ZBIO). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

NEW YORK, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Vistagen Therapeutics, Inc. (“Vistagen” or the “Company”) (NASDAQ: VTGN) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company. Should You Join The Vistagen Therapeutics Class Action Lawsuit?